{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:24:44Z","timestamp":1793975084398,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.metop.2026.100495","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:55:49Z","timestamp":1788796549000},"page":"100495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic modulation of the gut-brain axis in alcohol use disorder: A systematic review"],"prefix":"10.1016","volume":"32","author":[{"given":"Prabha","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhaleem","family":"Sideeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elfeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-2697","authenticated-orcid":false,"given":"Chencheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-3998","authenticated-orcid":false,"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2026.100495_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metop.2026.100495_bib2","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metop.2026.100495_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/19490976.2019.1580097","article-title":"Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption","volume":"10","author":"Bj\u00f8rkhaug","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metop.2026.100495_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metop.2026.100495_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","article-title":"The neuroactive potential of the human gut microbiota in quality of life and depression","volume":"4","author":"Valles-Colomer","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.metop.2026.100495_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102920","article-title":"Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review","volume":"78","author":"Subhani","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.metop.2026.100495_bib7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A randomized clinical trial of fecal microbiota transplant for alcohol use disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metop.2026.100495_bib8","first-page":"87","article-title":"Modulating the intestinal microbiota: therapeutic opportunities in liver disease","volume":"8","author":"Philips","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.metop.2026.100495_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot Study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metop.2026.100495_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.alcohol.2023.08.007","article-title":"Immune biomarkers in non-treatment-seeking heavy drinkers who used a probiotic supplement for 30 days: an open-label pilot study","volume":"114","author":"Monnig","year":"2024","journal-title":"Alcohol"},{"key":"10.1016\/j.metop.2026.100495_bib11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","article-title":"The beneficial effects of lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"Vatsalya","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metop.2026.100495_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.2007042","article-title":"Restoring an adequate dietary fiber intake by inulin supplementation: a pilot study showing an impact on gut microbiota and sociability in alcohol use disorder patients","volume":"14","author":"Amadieu","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metop.2026.100495_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146851","article-title":"Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: results from two human laboratory studies","volume":"1740","author":"Farokhnia","year":"2020","journal-title":"Brain Res"},{"key":"10.1016\/j.metop.2026.100495_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/alcalc\/agx024","article-title":"The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: a 'M\u00e9nage \u00e0 Trois'?","volume":"52","author":"Temko","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.metop.2026.100495_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159863","article-title":"Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial","volume":"7","author":"Klausen","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.metop.2026.100495_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170419","article-title":"Effects of dulaglutide on alcohol consuption during smoking cessation","volume":"8","author":"Probst","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.metop.2026.100495_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-Weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.metop.2026.100495_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127858","article-title":"Gut microbiota modulates neurotransmitter and gut-brain signaling","volume":"287","author":"Qu","year":"2024","journal-title":"Microbiol Res"},{"key":"10.1016\/j.metop.2026.100495_bib19","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.metop.2026.100495_bib20","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.metop.2026.100495_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.metop.2026.100495_bib22","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.20260003","article-title":"Oral semaglutide for alcohol use disorder: a randomized clinical trial","author":"Schacht","year":"2026","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.metop.2026.100495_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep4.1639","article-title":"Fecal Microbiota transplant in cirrhosis reduces gut microbial antibiotic resistance genes: analysis of two trials","volume":"5","author":"Bajaj","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metop.2026.100495_bib24","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(26)00305-3","article-title":"Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial","volume":"407","author":"Klausen","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.metop.2026.100495_bib25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term outcomes of Stool transplant in alcohol-associated hepatitis-analysis of clinical outcomes, relapse, Gut Microbiota and comparisons with standard care","volume":"12","author":"Philips","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.metop.2026.100495_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2025.100713","article-title":"Gut microbiome-liver-brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches","volume":"35","author":"Pich","year":"2025","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.metop.2026.100495_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2015.06.013","article-title":"The role of the gut-brain axis in alcohol use disorders","volume":"65","author":"Gorky","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.metop.2026.100495_bib28","doi-asserted-by":"crossref","DOI":"10.5662\/wjm.v14.i1.88519","article-title":"Gut microbiome in alcohol use disorder: implications for health outcomes and therapeutic strategies-a literature review","volume":"14","author":"Koutromanos","year":"2024","journal-title":"World J Methodol"},{"key":"10.1016\/j.metop.2026.100495_bib29","article-title":"Therapeutic interventions of gut-brain axis as novel strategies for treatment of alcohol use disorder associated cognitive and mood dysfunction","volume":"16","author":"Li","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.metop.2026.100495_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11011-025-01775-8","article-title":"Redox signaling in the heart and brain: the roles of nitric oxide and reactive oxygen species in disease and therapy","volume":"41","author":"Naderian","year":"2026","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.metop.2026.100495_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/mi\/6733477","article-title":"Unraveling the gut-liver-brain axis: microbiome, inflammation, and emerging therapeutic approaches","volume":"2025","author":"Aghara","year":"2025","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.metop.2026.100495_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10571-024-01496-z","article-title":"Gut-Brain axis and neuroinflammation: the role of gut permeability and the kynurenine pathway in neurological disorders","volume":"44","author":"Kearns","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.metop.2026.100495_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-025-03454-y","article-title":"Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway","volume":"22","author":"Cao","year":"2025","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.metop.2026.100495_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031160","article-title":"Interaction of the vagus nerve and serotonin in the gut-brain axis","volume":"26","author":"Hwang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metop.2026.100495_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-026-03763-w","article-title":"Molecular mechanisms and therapeutic potential of tryptophan metabolism in gut-brain signaling transduction: a narrative review","volume":"23","author":"Zhang","year":"2026","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.metop.2026.100495_bib36","article-title":"Interactions of bile acids and gut microbiota modulate neurological health: a comprehensive review on mechanisms and therapeutic potential of dietary phytochemicals","volume":"17","author":"Wang","year":"2026","journal-title":"Front Microbiol"},{"key":"10.1016\/j.metop.2026.100495_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211132","article-title":"The endocannabinoid System in human disease: molecular signaling, receptor pharmacology, and TherapeuticInnovation","volume":"26","author":"Serban","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metop.2026.100495_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01368-24","article-title":"Multi-level analysis of gut microbiome extracellular vesicles-host interaction reveals a connection to gut-brain axis signaling","volume":"13","author":"Mottawea","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.metop.2026.100495_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1358\/dnp.2010.23.3.1429490","article-title":"Role of the ghrelin system in alcoholism: acting on the growth hormone secretagogue receptor to treat alcohol-related diseases","volume":"23","author":"Leggio","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.metop.2026.100495_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13010067","article-title":"Alcohol use disorder and the gut-brain axis: a narrative review of the role of gut microbiota and implications for treatment","volume":"13","author":"Shukla","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.metop.2026.100495_bib41","article-title":"Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics","volume":"3","author":"Podlesny","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.metop.2026.100495_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104088","article-title":"Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis","volume":"81","author":"Rees","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.metop.2026.100495_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13040915","article-title":"A novel frontier in gut-brain axis research: the transplantation of fecal microbiota in neurodegenerative disorders","volume":"13","author":"Eslami","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.metop.2026.100495_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116412","article-title":"Probiotic therapeutics: a critical review of mechanisms, clinical efficacy, and the frontier of precision microbiome modulation","volume":"175","author":"Ashaolu","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.metop.2026.100495_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/apt.17049","article-title":"Review article: the future of microbiome-based therapeutics","volume":"56","author":"Gulliver","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metop.2026.100495_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12020234","article-title":"The potential impact of probiotics on human health: an update on their health-promoting properties","volume":"12","author":"Maftei","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.metop.2026.100495_bib47","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metop.2026.100495_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tibtech.2021.08.002","article-title":"Discovery and delivery strategies for engineered live biotherapeutic products","volume":"40","author":"Heavey","year":"2022","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.metop.2026.100495_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00203-025-04417-w","article-title":"Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study","volume":"207","author":"Sadhu","year":"2025","journal-title":"Arch Microbiol"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993682600054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993682600054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:27:37Z","timestamp":1793971657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258993682600054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S258993682600054X"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2026.100495","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic modulation of the gut-brain axis in alcohol use disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2026.100495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100495"}}